What's on the web on your pursuit, hobbies, interests and worries

GeneTherapy news

These Biopharmas Could Cure Genetic Diseases — At $5 Million Apiece

Investor's Business Daily - Nov 12, 2018
During its investor update this month, Novartis suggested its acquired gene therapy, AVXS-101, could be cost-effective at $4 million to $5 million. Novartis based the suggestion on a measure of the cost to treat the disease without the treatment, which ...

The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside.

UroToday - Nov 13, 2018
This review article describes our 15-year experience developing and testing IFN-based gene therapy. A comprehensive review was performed of all studies pertaining to IFN-based gene therapy for non-muscle invasive bladder cancer from 2003 to 2018.

Possible $4M Price for AVXS-101, 'Foundational' SMA Gene Therapy, Could Be Cost-Effective, Novartis Says

SMA News Today - Nov 9, 2018
Novartis may put a $4 million to $5 million price tag on its “one-time, potentially curative” gene therapy AVXS-101 for spinal muscular atrophy (SMA) and believes this could be cost-effective. “Four million dollars is a significant amount of money, but ...

Gene Therapy - premium items on eBay

Gene Therapy Technologies, Applications and Regulations: From Laboratory to Clin


NEW Cancer Gene Therapy (Contemporary Cancer Research)


Understanding Gene Therapy (MEDICAL PERSPECTIVES SERIES)-ExLibrary


>> Go to all great Gene Therapy deals on eBay

Gene Therapy pictures on the web

>> Show

Gene Therapy videos

SMA Type 1: How Gene Therapy Works

Connect with a specialist: http://bit.ly/2nIxt7t Meet Jerry Mendell, MD: http://bit.ly/2nCirzT More about SMA Type 1: http://bit.ly/2nF1aWM More on Research: ...

Defeating Sickle Cell Disease with Stem Cells Gene Therapy: Stem Cells in Your Face, Episode 2

Produced by Todd Dubnicoff and Kevin McCormack at Cailfornia Institute for Regenerative Medicine (CIRM) Using a mix of science, humor and easy to ...

Medicine for members: Gene therapy for haemophilia

A Medicine for Members talk given on 22 April 2014 at the Royal Free Hospital by Professor Amit Nathwani.

Gene Therapy Reveals Unexpected Immunity

Gene Therapy Reveals Unexpected Immunity in Duchenne Muscular Dystrophy.

Gene Therapy Explained

Many diseases have a genetic basis, which means that the disease is caused by mutated genes which provide incorrect instructions that cause the cell to ...